Andrea Botticelli

Pubblicazioni

Titolo Pubblicato in Anno
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis CANCERS 2024
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey TUMORI 2024
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients CURRENT ONCOLOGY REPORTS 2024
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line JOURNAL OF TRANSLATIONAL MEDICINE 2024
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study THE ONCOLOGIST 2024
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis BMC CANCER 2024
Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2024
The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients PATHOLOGY RESEARCH AND PRACTICE 2024
The multidisciplinary management of locally advanced rectal cancer EXPERT REVIEW OF ANTICANCER THERAPY 2024
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis BMC CANCER 2024
Correction to: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (npj Breast Cancer, (2024), 10, 1, (58), 10.1038/s41523-024-00657-z) NPJ BREAST CANCER 2024
Assessing risks and knowledge gaps on the impact of systemic therapies in early breast cancer on female fertility: A systematic review of the literature CANCER TREATMENT REVIEWS 2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature CANCERS 2024
Pregnancy-associated breast cancer: a diagnostic and therapeutic challenge DIAGNOSTICS 2023
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach CANCER IMMUNOLOGY, IMMUNOTHERAPY 2023
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
86P {KRAS} G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma JOURNAL OF THORACIC ONCOLOGY 2023
Risk of Oral Squamous Cell Carcinoma in One Hundred Patients with Oral Lichen Planus: A Follow-Up Study of Umberto I University Hospital of Rome CANCERS 2023
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma LUNG CANCER 2023
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer CLINICAL CANCER RESEARCH 2023

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma